Murnyák Balázs, Bodoki Levente, Vincze Melinda, Griger Zoltán, Csonka Tamás, Szepesi Rita, Kurucz Andrea, Dankó Katalin, Hortobágyi Tibor
Division of Neuropathology, Institute of Pathology.
Institute of Internal Medicine, Third Department of Internal Medicine, Division of Clinical Immunology.
Open Med (Wars). 2015 Feb 26;10(1):188-193. doi: 10.1515/med-2015-0030. eCollection 2015.
Inclusion body myositis is a rare, late-onset myopathy. Both inflammatory and myodegenerative features play an important role in their pathogenesis. Overlapping clinicopathological entities are the familial inclusion body myopathies with or without dementia. These myopathies share several clinical and pathological features with the sporadic inflammatory disease. Therefore, better understanding of the genetic basis and pathomechanism of these rare familial cases may advance our knowledge and enable more effective treatment options in sporadic IBM, which is currently considered a relentlessly progressive incurable disease.
包涵体肌炎是一种罕见的迟发性肌病。炎症和肌退行性变特征在其发病机制中都起着重要作用。重叠的临床病理实体是伴或不伴痴呆的家族性包涵体肌病。这些肌病与散发性炎症性疾病有一些临床和病理特征相同。因此,更好地了解这些罕见家族性病例的遗传基础和发病机制,可能会增进我们的认识,并为散发性包涵体肌炎提供更有效的治疗选择,目前散发性包涵体肌炎被认为是一种 relentlessly progressive incurable disease。 (此处“relentlessly progressive incurable disease”可直译为“无情进展的不治之症” ,但结合语境推测可能是指“进行性不可治愈的疾病” ,具体含义可根据更多背景信息确定)